EXEMESTANE
- Product NDC
- 69097-316
- 11-digit product format
- 690970316
- Labeler code
- 69097
- Product ID
- 69097-316_60b57295-ef43-4721-94c4-58a4c5689420
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- exemestane
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA210323
- Marketing category
- ANDA
- Marketing start
- 2018-04-27
- Substance
- EXEMESTANE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- EXEMESTANE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EXEMESTANE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | NY22HMQ4BX |
| Rxcui | 310261 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-316-02 | EXEMESTANE | 30 in 1 BOTTLE | TABLET | 30 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-316 | EXEMESTANE TABLET [CIPLA USA INC.] | 7 | Current NDC, Legacy NDC, 1 package rows | 20250121_abde1ccd-0ec9-40d4-b205-fbc00f5878b9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-316-02 | 69097031602 | 30 TABLET in 1 BOTTLE (69097-316-02) | 30 tablet | 2018-04-27 | 0000-00-00 | No | No | Current |